Novonesis (Novozymes) B/ DK0060336014 /
29/08/2024 10:41:15 | Chg. +5.30 | Volume | Bid27/08/2024 | Ask15/08/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
466.85DKK | +1.15% | 887 Turnover: 410,941.15 |
-Bid Size: - | -Ask Size: - | 129.56 bill.DKK | 0.90% | 42.78 |
Assets
|
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
2021 IFRS in mill. DKK |
2022 IFRS in mill. DKK |
2023 IFRS in mill. DKK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 10,212 | 8,930 | 9,309 | 9,577 | 10,559 | ||||||
Intangible Assets | 1,926 | 2,554 | 5,024 | 4,698 | 4,532 | ||||||
Long-Term Investments | 22 | 21 | 30 | 92 | 205 | ||||||
Fixed Assets | - | - | - | 18,742 | 18,929 | ||||||
Inventories | 2,613 | 2,361 | 2,992 | 3,803 | 3,627 | ||||||
Accounts Receivable | 2,864 | 2,549 | 2,948 | 3,454 | 3,702 | ||||||
Cash and Cash Equivalents | 711 | 1,181 | 963 | 1,041 | 1,116 | ||||||
Current Assets | 6,988 | 6,888 | 7,823 | 9,241 | 9,462 | ||||||
Total Assets | 20,375 | 20,510 | 24,767 | 27,983 | 28,391 |
Liabilities
|
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
2021 IFRS in mill. DKK |
2022 IFRS in mill. DKK |
2023 IFRS in mill. DKK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,117 | 1,100 | 1,490 | 3,454 | 1,616 | ||||||
Long-term debt | 2,775 | 3,254 | 4,397 | 3,619 | 4,329 | ||||||
Liabilities to Banks | 4,186 | 4,563 | 6,536 | - | - | ||||||
Provisions | 1,553 | 1,745 | 1,997 | 129 | 2,077 | ||||||
Liabilities | 8,957 | 9,266 | 12,561 | 13,755 | 14,040 | ||||||
Share Capital | 582 | 570 | 564 | - | - | ||||||
Total Equity | 11,468 | 11,233 | 11,827 | 13,837 | 13,978 | ||||||
Minority Interests | 12 | 11 | 379 | 391 | 373 | ||||||
Total liabilities equity | 20,375 | 20,510 | 24,767 | 27,983 | 28,391 |
Income Statement
|
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
2021 IFRS in mill. DKK |
2022 IFRS in mill. DKK |
2023 IFRS in mill. DKK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 14,374 | 14,012 | 14,951 | 17,553 | 17,899 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 4,039 | 3,652 | 4,007 | 4,561 | 3,976 | ||||||
Interest Income | -235 | -127 | -79 | 2 | -49 | ||||||
Income Before Taxes | 3,799 | 3,521 | 3,924 | - | - | ||||||
Income Taxes | 644 | 695 | 779 | 870 | 870 | ||||||
Minority Interests Profit | -1 | -1 | 1 | 10 | 15 | ||||||
Net Income | 3,154 | 2,825 | 3,145 | 3,686 | 3,024 |
Per Share
Cash Flow
|
2019 IFRS in mill. DKK |
2020 IFRS in mill. DKK |
2021 IFRS in mill. DKK |
2022 IFRS in mill. DKK |
2023 IFRS in mill. DKK |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 3,196 | 4,355 | 4,062 | 4,006 | 4,152 | ||||||
Cash Flow from Investing Activities | -561 | -1,524 | -2,747 | -2,672 | -2,133 | ||||||
Cash Flow from Financing | -2,644 | -2,314 | -1,586 | -1,250 | -1,889 | ||||||
Decrease / Increase in Cash | -12 | 470 | -218 | - | - | ||||||
Employees | 6,125 | 6,185 | 6,527 | 6,781 | 6,756 |